Kidney Res Clin Pract > Volume 42(1); 2023 > Article |
|
Funding
The Xijing Hospital discipline promoting plan (Reference number: XJZT21L15), National Natural Science Foundation of China grants (Reference number: 81670655), and Key projects of Shaanxi province (Reference number: 2017ZDXM-SF-045) supported this study.
Data sharing statement
The data presented in this study are available on request from the corresponding author.
Authors’ contributions
Conceptualization: SS
Data curation: YQ, JZ, ZY
Formal analysis: YQ, YW, ZY, YZ
Funding acquisition: SS
Methodology: XW
Project administration: SS
Software: YQ, XW
Writing–original draft: YQ
Writing–review & editing: SS, JZ, ZY, YZ
All authors read and approved the final manuscript.
Characteristic | Value |
---|---|
Male sex | 6,004 (57.0) |
Age (yr) | 38.73 ± 16.53 |
No. of glomeruli | 22.19 ± 10.34 |
Asymptomatic urinary abnormalities | 1,486 (14.1) |
Chronic nephritic syndrome | 5,429 (51.6) |
Nephrotic syndrome | 3,157 (30.0) |
Acute kidney injury | 405 (3.8) |
Rapidly progressive glomerulonephritis | 29 (0.3) |
Isolated microscopic hematuria | 879 (8.3) |
Renal insufficiencya | 1,850 (17.6) |
Hypertension | 3,147 (29.9) |
Hyperlipidemia | 3,963 (37.6) |
Renal anemia | 1,066 (10.1) |
Data are expressed as number (%) and mean ± standard deviation.
CreGN, crescentic glomerulonephritis; DN, diabetic nephropathy; EnPGN, endocapillary proliferative glomerulonephritis; FSGS, focal segmental glomerulosclerosis; HBVN, hepatitis B associated nephropathy; HSPN, Henoch-Schönlein purpura nephritis; HTN, hypertensive nephropathy; IgAN, immunoglobulin A nephropathy; IgMN, immunoglobulin M nephropathy; LN, systemic lupus erythematosus nephritis; MCD, minimal change disease; MN, membranous nephropathy; MPGN, membranoproliferative glomerulonephritis; MsPGN, mesangial proliferative glomerulonephritis; SCGN, sclerosing glomerulonephritis; SVARD, systemic vasculitis-associated renal damage; TIN, tubulointerstitial nephritis.
Yunlong Qin
https://orcid.org/0000-0002-9442-4650
Jin Zhao
https://orcid.org/0000-0001-5893-2634
Xiao Wei
https://orcid.org/0000-0002-4483-1346
Yuwei Wang
https://orcid.org/0000-0002-2353-9944
Zixian Yu
https://orcid.org/0000-0002-0990-7691
Yumeng Zhang
https://orcid.org/0000-0001-5793-9519
Shiren Sun
https://orcid.org/0000-0003-3345-3543